Insufficient scRNA-seq data for expression of ZACN at single-cell level.
Insufficient scRNA-seq data for expression of ZACN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 94% | 141.77 | 904 / 966 | 0% | 0.01 | 2 / 527 |
spleen | 89% | 9.07 | 215 / 241 | 0% | 0 | 0 / 0 |
prostate | 87% | 19.93 | 213 / 245 | 0% | 0.00 | 1 / 502 |
bladder | 81% | 3.76 | 17 / 21 | 1% | 0.03 | 6 / 504 |
brain | 78% | 5.54 | 2064 / 2642 | 0% | 0.01 | 3 / 705 |
lung | 74% | 3.92 | 429 / 578 | 1% | 0.20 | 15 / 1155 |
thymus | 72% | 5.14 | 467 / 653 | 1% | 0.03 | 5 / 605 |
stomach | 71% | 4.12 | 256 / 359 | 1% | 0.01 | 2 / 286 |
pancreas | 70% | 3.42 | 231 / 328 | 1% | 0.05 | 2 / 178 |
breast | 71% | 3.41 | 324 / 459 | 1% | 0.01 | 6 / 1118 |
peripheral blood | 71% | 4.16 | 659 / 929 | 0% | 0 | 0 / 0 |
skin | 70% | 3.87 | 1273 / 1809 | 0% | 0.00 | 1 / 472 |
adrenal gland | 69% | 2.79 | 177 / 258 | 0% | 0 | 0 / 230 |
adipose | 64% | 2.86 | 774 / 1204 | 0% | 0 | 0 / 0 |
ovary | 64% | 2.66 | 115 / 180 | 0% | 0.01 | 1 / 430 |
esophagus | 63% | 3.06 | 904 / 1445 | 0% | 0 | 0 / 183 |
kidney | 57% | 2.44 | 51 / 89 | 0% | 0.01 | 3 / 901 |
uterus | 55% | 2.18 | 93 / 170 | 0% | 0.01 | 1 / 459 |
blood vessel | 50% | 1.84 | 663 / 1335 | 0% | 0 | 0 / 0 |
liver | 47% | 1.69 | 107 / 226 | 0% | 0 | 0 / 406 |
muscle | 37% | 1.20 | 297 / 803 | 0% | 0 | 0 / 0 |
heart | 28% | 0.84 | 242 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_0010043 | Biological process | response to zinc ion |
GO_0098655 | Biological process | monoatomic cation transmembrane transport |
GO_1902495 | Cellular component | transmembrane transporter complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0160128 | Molecular function | pH-gated monoatomic ion channel activity |
GO_0005230 | Molecular function | extracellular ligand-gated monoatomic ion channel activity |
GO_0099094 | Molecular function | ligand-gated monoatomic cation channel activity |
GO_0015276 | Molecular function | ligand-gated monoatomic ion channel activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | ZACN |
Protein name | Ligand-gated cation channel ZACN (Ligand-gated ion channel zinc-activated 1) (Ligand-gated ion-channel receptor L2) (Zinc-activated channel) |
Synonyms | LGICZ L2 LGICZ1 ZAC |
Description | FUNCTION: Ligand-gated cation channel that allows the movement of sodium and potassium monoatomic cations across cell membranes when activated by zinc (Zn2+), copper (Cu2+), and changes in pH . Could also transport cesium . . |
Accessions | ENST00000334586.10 [Q401N2-1] Q401N2 ENST00000425015.5 [Q401N2-2] ENST00000421794.1 [Q401N2-3] |